Young Ran Park

973 total citations · 1 hit paper
21 papers, 788 citations indexed

About

Young Ran Park is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Young Ran Park has authored 21 papers receiving a total of 788 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 10 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Young Ran Park's work include Cancer, Hypoxia, and Metabolism (4 papers), Bone Metabolism and Diseases (4 papers) and Bone health and treatments (3 papers). Young Ran Park is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Bone Metabolism and Diseases (4 papers) and Bone health and treatments (3 papers). Young Ran Park collaborates with scholars based in South Korea and China. Young Ran Park's co-authors include Hyun‐Joo Kong, Eun Sook Lee, Young‐Joo Won, Seri Hong, Kyu‐Won Jung, Se Lim Kim, Yunjo Soh, Sang Wook Kim, Soo Teik Lee and Seong‐Hun Kim and has published in prestigious journals such as Annals of Oncology, European Journal of Pharmacology and Journal of Cellular Physiology.

In The Last Decade

Young Ran Park

19 papers receiving 782 citations

Hit Papers

Cancer Statistics in Korea: Incidence, Mortality, Surviva... 2020 2026 2022 2024 2020 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017
    2020 351 citations Seri Hong, Young‐Joo Won et al. Cancer Research and Treatment profile →

Peers

Young Ran Park
Lan Liu China
Michail Mitsis Greece
Yan Xue China
Shuling Huang China
Xuelong Jiao China
Zhe Huang China
Jianhui Yang China
Lan Liu China
Young Ran Park
Citations per year, relative to Young Ran Park Young Ran Park (= 1×) peers Lan Liu

Countries citing papers authored by Young Ran Park

Since Specialization
Citations

This map shows the geographic impact of Young Ran Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Young Ran Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Young Ran Park more than expected).

Fields of papers citing papers by Young Ran Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Young Ran Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Young Ran Park. The network helps show where Young Ran Park may publish in the future.

Co-authorship network of co-authors of Young Ran Park

This figure shows the co-authorship network connecting the top 25 collaborators of Young Ran Park. A scholar is included among the top collaborators of Young Ran Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Young Ran Park. Young Ran Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cho, Eun-Hee, Chang Hun Lee, Steve Oh, et al.. (2025). Fatty Liver Index Dynamics as a Predictor of Hepatocellular Carcinoma in Patients with Type 2 Diabetes Mellitus and Non-Cirrhotic Livers. Endocrinology and Metabolism. 40(6). 883–892.
2.
Shen, Chen, et al.. (2024). Interaction between p21‐activated kinase 4 and β‐catenin as a novel pathway for PTH‐dependent osteoblast activation. Journal of Cellular Physiology. 239(6). e31245–e31245.
3.
Nam, Miso, et al.. (2022). Metabolic Profiling of Chestnut Shell (Castanea crenata) Cultivars Using UPLC-QTOF-MS and Their Antioxidant Capacity. Biomolecules. 12(12). 1797–1797. 5 indexed citations
4.
Park, Young Ran, et al.. (2021). 2E‐Decene‐4,6‐diyn‐1‐ol‐acetate inhibits osteoclastogenesis through mitogen‐activated protein kinase‐c‐Fos‐NFATc1 signalling pathways. Clinical and Experimental Pharmacology and Physiology. 49(3). 341–349. 4 indexed citations
5.
Hong, Seri, Young‐Joo Won, Young Ran Park, et al.. (2020). Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017. Cancer Research and Treatment. 52(2). 335–350. 351 indexed citations breakdown →
6.
Park, Young Ran, Chan‐Il Park, & Yunjo Soh. (2020). Antioxidant and Anti-Inflammatory Effects of NCW Peptide from Clam Worm (Marphysa sanguinea). Journal of Microbiology and Biotechnology. 30(9). 1387–1394. 24 indexed citations
7.
Park, Young Ran, Soo Teik Lee, Se Lim Kim, et al.. (2018). Down-regulation of miR-9 promotes epithelial mesenchymal transition via regulating anoctamin-1 (ANO1) in CRC cells. Cancer Genetics. 231-232. 22–31. 27 indexed citations
8.
Kim, Se‐Lim, et al.. (2018). Lipocalin 2 inversely regulates TRAIL sensitivity through p38 MAPK-mediated DR5 regulation in colorectal cancer. International Journal of Oncology. 53(6). 2789–2799. 9 indexed citations
9.
Park, Young Ran, Seung Young Seo, Se Lim Kim, et al.. (2018). MiRNA-206 suppresses PGE2-induced colorectal cancer cell proliferation, migration, and invasion by targetting TM4SF1. Bioscience Reports. 38(5). 50 indexed citations
10.
Kim, Se‐Lim, Soo Teik Lee, Young Ran Park, et al.. (2017). Lipocalin 2 negatively regulates cell proliferation and epithelial to mesenchymal transition through changing metabolic gene expression in colorectal cancer. Cancer Science. 108(11). 2176–2186. 43 indexed citations
11.
Kim, Se Lim, Young Ran Park, Soo Teik Lee, & Sang‐Wook Kim. (2017). Parthenolide suppresses hypoxia-inducible factor-1α signaling and hypoxia induced epithelial-mesenchymal transition in colorectal cancer. International Journal of Oncology. 51(6). 1809–1820. 31 indexed citations
12.
Kim, Se Lim, et al.. (2017). Parthenolide promotes apoptotic cell death and inhibits the migration and invasion of SW620 cells. Intestinal Research. 15(2). 174–174. 31 indexed citations
13.
Park, Young Ran, Soo Teik Lee, Se Lim Kim, et al.. (2016). MicroRNA-9 suppresses cell migration and invasion through downregulation of TM4SF1 in colorectal cancer. International Journal of Oncology. 48(5). 2135–2413. 66 indexed citations
14.
15.
Kim, Seong‐Hun, Young Ran Park, Yu‐Chuan Liu, et al.. (2016). Combined Parthenolide and Balsalazide Have Enhanced Antitumor Efficacy Through Blockade of NF-κB Activation. Molecular Cancer Research. 15(2). 141–151. 16 indexed citations
16.
Kim, Se‐Lim, Yu‐Chuan Liu, Young Ran Park, et al.. (2014). Parthenolide enhances sensitivity of colorectal cancer cells to TRAIL by inducing death receptor 5 and promotes TRAIL-induced apoptosis. International Journal of Oncology. 46(3). 1121–1130. 19 indexed citations
17.
Nepal, Manoj, Young‐Dae Gong, Young Ran Park, & Yunjo Soh. (2011). An activator of PHD2, KRH102140, decreases angiogenesis via inhibition of HIF‐1α. Cell Biochemistry and Function. 29(2). 126–134. 25 indexed citations
18.
Choi, Hwa Jung, et al.. (2010). Inhibition of osteoclastogenic differentiation by Ikarisoside A in RAW 264.7 cells via JNK and NF-κB signaling pathways. European Journal of Pharmacology. 636(1-3). 28–35. 61 indexed citations
19.
Park, Young Ran, Jae Soon Eun, Hwa Jung Choi, et al.. (2009). Hexane-Soluble Fraction of the Common Fig, Ficus carica, Inhibits Osteoclast Differentiation in Murine Bone Marrow-Derived Macrophages and RAW 264.7 Cells. Korean Journal of Physiology and Pharmacology. 13(6). 417–417. 9 indexed citations
20.
Yeom, Chang Hwan, Youn Seon Choi, Hye Ree Lee, et al.. (2000). The comparison of the medical costs and quality of life in terminal cancer patients by the types of medical facilities.. Gajeong yihag hoeji. 21(3). 332–343. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lan Liu Breakdown of academic impact, for papers by Michail Mitsis Breakdown of academic impact, for papers by Yan Xue Breakdown of academic impact, for papers by Shuling Huang Breakdown of academic impact, for papers by Xuelong Jiao Breakdown of academic impact, for papers by Zhe Huang Breakdown of academic impact, for papers by Jianhui Yang
Rankless by CCL
2026